Christopher Sabatino received his Ph.D. in Biomedical Engineering from Rutgers University and the University of Medicine and Dentistry of New Jersey. He is currently a Senior Marketing Program Manager for the Biologics Division of Medtronic Spinal & Biologics. His role includes the support of current Medtronic orthobiologics products for orthopaedic applications, and examining potential future applications of rhBMP-2 (INFUSE® Bone Graft). He has 32 peer reviewed publications/presentations, including a book chapter on nucleus pulposus replacement technologies.
Dr. Sabatino spoke at today’s (2-16-12) UB Orthopaedics & Sports Medicine Grand Rounds on “Bone Graft Options”. His visit to Buffalo was arranged by UBOSM spine surgeon Lindsey Clark, M.D.